Effectiveness and safety of antithrombotic drugs used for stroke prevention in nonvalvular atrial fibrillation (Esc-Fa Study)

Background Effectiveness and safety of vitamin K antagonists (VKAs), antiplatelets, or no treatment for stroke prevention in atrial fibrillation (AF) have not been assessed in our setting. Data Sources: SIDIAP database; anonymized clinical information from electronic clinical records in primary care...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2015-08, Vol.37 (8), p.e12-e12
Hauptverfasser:	Giner-Soriano, M, Morros, R, Vedia Urgell, C, Roso-Llorach, A, Castells, X, Capellà, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Health risk assessment Internal Medicine Medical Education Mortality Primary care Stroke
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background Effectiveness and safety of vitamin K antagonists (VKAs), antiplatelets, or no treatment for stroke prevention in atrial fibrillation (AF) have not been assessed in our setting. Data Sources: SIDIAP database; anonymized clinical information from electronic clinical records in primary care of 5,800,000 people from Catalonia on sociodemographics, comorbidities, medical procedures, clinical parameters, laboratory data, and pharmacy invoicing data.
ISSN:	0149-2918 1879-114X
DOI:	10.1016/j.clinthera.2015.05.044